Kontour (Xi'an) Medical Technology Past Earnings Performance
Past criteria checks 2/6
Kontour (Xi'an) Medical Technology has been growing earnings at an average annual rate of 8.3%, while the Medical Equipment industry saw earnings growing at 8% annually. Revenues have been growing at an average rate of 13.9% per year. Kontour (Xi'an) Medical Technology's return on equity is 12.4%, and it has net margins of 27.1%.
Key information
8.3%
Earnings growth rate
-0.3%
EPS growth rate
Medical Equipment Industry Growth | 16.0% |
Revenue growth rate | 13.9% |
Return on equity | 12.4% |
Net Margin | 27.1% |
Last Earnings Update | 31 Mar 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses BreakdownBeta
How Kontour (Xi'an) Medical Technology makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
31 Mar 24 | 280 | 76 | 108 | 18 |
31 Dec 23 | 275 | 76 | 107 | 18 |
30 Sep 23 | 268 | 75 | 107 | 21 |
30 Jun 23 | 260 | 76 | 105 | 21 |
31 Mar 23 | 251 | 77 | 100 | 20 |
31 Dec 22 | 240 | 76 | 92 | 18 |
30 Sep 22 | 240 | 85 | 86 | 20 |
30 Jun 22 | 232 | 86 | 81 | 17 |
31 Mar 22 | 225 | 86 | 77 | 15 |
31 Dec 21 | 213 | 82 | 75 | 17 |
30 Sep 21 | 202 | 73 | 73 | 17 |
30 Jun 21 | 190 | 64 | 74 | 17 |
31 Mar 21 | 180 | 59 | 71 | 19 |
31 Dec 20 | 164 | 52 | 64 | 17 |
01 Jan 20 | 148 | 52 | 57 | 11 |
01 Jan 19 | 110 | 22 | 50 | 8 |
Quality Earnings: 688314 has high quality earnings.
Growing Profit Margin: 688314's current net profit margins (27.1%) are lower than last year (30.7%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 688314's earnings have grown by 8.3% per year over the past 5 years.
Accelerating Growth: 688314's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: 688314 had negative earnings growth (-1.4%) over the past year, making it difficult to compare to the Medical Equipment industry average (-1.3%).
Return on Equity
High ROE: 688314's Return on Equity (12.4%) is considered low.